BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26005873)

  • 21. Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
    Riegersperger M; Covic A; Goldsmith D
    Int Urol Nephrol; 2011 Jun; 43(2):441-9. PubMed ID: 21547469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic disorders resulting in hyper- or hypouricemia.
    Sebesta I
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):398-403. PubMed ID: 23089275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uric acid: bystander or culprit in hypertension and progressive renal disease?
    Menè P; Punzo G
    J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.
    Gaubert M; Bardin T; Cohen-Solal A; Diévart F; Fauvel JP; Guieu R; Sadrin S; Maixent JM; Galinier M; Paganelli F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 33561034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
    Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pathophysiology of Uric Acid on Renal Diseases.
    Sánchez-Lozada LG
    Contrib Nephrol; 2018; 192():17-24. PubMed ID: 29393088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights.
    Gulab A; Torres R; Pelayo J; Lo KB; Shahzad A; Pradhan S; Rangaswami J
    Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):547-556. PubMed ID: 34112023
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
    Yanai H; Adachi H; Hakoshima M; Katsuyama H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
    Schils R; Krzesinski JM
    Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperuricemia, urate deposition and the association with hypertension.
    Mancia G; Grassi G; Borghi C
    Curr Med Res Opin; 2015; 31 Suppl 2():15-9. PubMed ID: 26414732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid and transplantation.
    Mazali FC; Mazzali M
    Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hyperuricemia in vascular disorders.
    Edwards NL
    Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid and hypertension.
    Schachter M
    Curr Pharm Des; 2005; 11(32):4139-43. PubMed ID: 16375735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uric acid as a factor in the metabolic syndrome.
    Borges RL; Ribeiro AB; Zanella MT; Batista MC
    Curr Hypertens Rep; 2010 Apr; 12(2):113-9. PubMed ID: 20424936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
    Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Goldberg A; Garcia-Arroyo F; Sasai F; Rodriguez-Iturbe B; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2021; 52(10-11):837-844. PubMed ID: 34673651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.
    Sato Y; Feig DI; Stack AG; Kang DH; Lanaspa MA; Ejaz AA; Sánchez-Lozada LG; Kuwabara M; Borghi C; Johnson RJ
    Nat Rev Nephrol; 2019 Dec; 15(12):767-775. PubMed ID: 31296965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.